PANAROTTO, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 744
EU - Europa 643
AS - Asia 325
AF - Africa 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 1.722
Nazione #
US - Stati Uniti d'America 740
DE - Germania 166
CN - Cina 153
UA - Ucraina 119
PL - Polonia 98
IT - Italia 76
SG - Singapore 73
FI - Finlandia 41
RU - Federazione Russa 41
GB - Regno Unito 35
HK - Hong Kong 34
IN - India 33
FR - Francia 23
TR - Turchia 23
IE - Irlanda 18
SE - Svezia 15
BE - Belgio 8
CA - Canada 4
VN - Vietnam 4
BR - Brasile 2
EU - Europa 2
IR - Iran 2
MU - Mauritius 2
AR - Argentina 1
AU - Australia 1
BY - Bielorussia 1
ES - Italia 1
ID - Indonesia 1
IM - Isola di Man 1
KR - Corea 1
NZ - Nuova Zelanda 1
SD - Sudan 1
TW - Taiwan 1
Totale 1.722
Città #
Warsaw 98
Jacksonville 90
Chandler 76
Ann Arbor 73
Singapore 64
Fairfield 62
Woodbridge 51
Cambridge 39
Ashburn 36
Princeton 36
Hong Kong 34
Seattle 34
Houston 29
Beijing 26
Nanjing 25
Brescia 24
Wilmington 24
Helsinki 23
New York 20
Dublin 18
Istanbul 16
Hebei 15
Shanghai 11
Nanchang 10
Des Moines 9
Milan 9
Shenyang 9
Brussels 8
Kocaeli 7
Los Angeles 7
Changsha 6
Jiaxing 6
Jinan 6
Lanzhou 6
Nürnberg 6
Tianjin 6
Bologna 4
Dong Ket 4
Moscow 4
San Francisco 4
Changchun 3
Guangzhou 3
Hangzhou 3
Kunming 3
San Diego 3
Zhengzhou 3
Haikou 2
Lodi 2
London 2
Munich 2
Norwalk 2
Porto Alegre 2
Rocca Di Papa 2
Taiyuan 2
Taizhou 2
Toronto 2
Treviso 2
Verona 2
Ardabil 1
Auckland 1
Boardman 1
Bosa 1
Canberra 1
Castiglione Olona 1
Chicago 1
Dearborn 1
Douglas 1
Frankfurt am Main 1
Fuzhou 1
Gunzenhausen 1
Hyderabad 1
Iseo 1
Islington 1
Jakarta 1
Lappeenranta 1
Leipzig 1
Mantova 1
Marano Vicentino 1
Marche 1
Minsk 1
Monmouth Junction 1
Nanning 1
Ningbo 1
North York 1
Ottawa 1
Pars 1
Phoenix 1
Pune 1
Quattro Castella 1
Redmond 1
Romola 1
Sochi 1
Westminster 1
Zaragoza 1
Totale 1.113
Nome #
Genetic mutation screening in an Italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients 254
Genetic mutation screening in an Italian cohort of non-syndromic pheochromocytoma/paraganglioma patients. 144
Should we screen non-syndromic pheochromocytoma paraganglioma patients for succinate dehydrogenase mutations? 129
Lo screening genetico del carcinoma midollare tiroideo apparentemente sporadico. 108
Genetic Mutation Screening in an Italian Cohort of Non-Syndromic Pheochromocytoma/Paraganglioma Patients 108
p.Ser891Ala RET gene mutations in medullary thyroid cancer: Phenotypical and genealogical characterization of 28 apparently unrelated kindreds and founder effect uncovering in Northern Italy 107
BASSA PENETRANZA E SPICCATA VARIABILITÀ FENOTIPICA IN UNA NUOVA MUTAZIONE CON EFFETTO FONDATORE ASSOCIATA A FEOCROMOCITOMA/PARAGANGLIOMA. 104
Revised sequence of the alpha 1B adrenergic receptor promoter region. 98
I pazienti affetti da feocromocitoma/paraganglioma non sindromico devono essere sottoposti a screening per mutazioni della succinato deidrogenasi? 85
PHEOCHROMOCYTOMA MAY OCCUR IN KINDREDS WITH RET MUTATION ASSOCIATED WITH FAMILIAL MEDULLARY THYROID CARCINOMA (SER891ALA) 78
ASYMPTOMATIC BILATERAL PHEOCHROMOCYTOMA IN VHL MUTATION (VAL84LEU) CARRIER IDENTIFIED BY FAMILY GENETIC SCREENING 76
GENE POLYMORPHISM OF THE 5-LIPOXYGENASE (ALOX) PATHWAY IS NOT CONSISTENTLY ASSOCIATED WITH JUVENILE STROKE OR CAROTID ATHEROSCLEROSIS PHENOTYPES IN THE ITALIAN POPULATION. 75
Evidence of a founder effect in thirteen families with medullary thyroid cancer carryng RET ser891ala mutation. 74
Genetic screening in apparently sporadic medullary thyroid cancer: a ten experience. 71
Gene polymorphism of the 5-lipoxygenase (ALOX) pathway is not consistently associated with juvenile stroke or carotid atherosclerosis phenotypes in the Italian population 59
Gene polymorphism of the 5-lipoxygenase (ALOX) pathway is not consistently associated with juvenile stroke or carotid atherosclerosis phenotypes in the Italian population 57
FAILURE TO REPLICATE THE ASSOCIATION OF UROMODULIN GENE VARIANT RS 13333226 WITH HYPERTENSION IN A GENERAL POPULATION STUDY 53
I pazienti affetti da feocromocitoma/paraganglioma non sindromico devono essere sottoposti a screening per mutazioni della succinato deidrogenasi? 48
Pheochromocytoma/paraganglioma: Diagnosis and treatment 19
Totale 1.747
Categoria #
all - tutte 7.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.530


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020268 0 0 0 0 0 45 36 52 25 58 28 24
2020/2021240 3 28 6 28 9 30 8 31 39 29 20 9
2021/2022150 6 19 1 16 4 8 3 11 7 23 12 40
2022/2023212 22 8 1 9 30 40 0 32 45 2 16 7
2023/2024149 14 1 14 26 5 21 4 2 36 2 2 22
2024/2025126 0 8 6 49 29 34 0 0 0 0 0 0
Totale 1.747